![](/img/cover-not-exists.png)
OC-0281 Phase I/II trial of hafnium oxide nanoparticles activated by SBRT in the treatment of liver cancers
Chajon, E., Pracht, M., De Baere, T., N’Guyen, F., Bronowicki, J., Vendrely, V., Baumann, A., Croisé-Laurent, V., Rio, E., Rolland, Y., Le Sourd, S., Gustin, P., Perret, C., Mornex, F., Peiffert, D.,Volume:
133
Language:
english
Journal:
Radiotherapy and Oncology
DOI:
10.1016/s0167-8140(19)30701-7
Date:
April, 2019
File:
PDF, 138 KB
english, 2019